New Drugs and Novel Cellular Targets against Tuberculosis
Author Contributions
Funding
Conflicts of Interest
References
- World Health Organization. Global Tuberculosis Report 2020; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Lara-Espinosa, J.V.; Arce-Aceves, M.F.; López-Torres, M.O.; Lozano-Ordaz, V.; Mata-Espinosa, D.; Barrios-Payán, J.; Silva-Islas, C.A.; Maldonado, P.D.; Marquina-Castillo, B.; Hernández-Pando, R. Effect of curcumin in experimental pulmonary tuberculosis: Antimycobacterial activity in the lungs and anti-inflammatory effect in the brain. Int. J. Mol. Sci. 2022, 23, 1964. [Google Scholar] [CrossRef] [PubMed]
- Lara-Espinosa, J.V.; Santana-Martínez, R.A.; Maldonado, P.D.; Zetter, M.; Becerril-Villanueva, E.; Pérez-Sánchez, G.; Pavón, L.; Mata-Espinosa, D.; Barrios-Payán, J.; López-Torres, M.O.; et al. Experimental pulmonary tuberculosis in the absence of detectable brain infection induces neuroinflammation and behavioural abnormalities in male balb/c mice. Int. J. Mol. Sci. 2020, 21, 9483. [Google Scholar] [CrossRef] [PubMed]
- Ezquerra-Aznárez, J.M.; Degiacomi, G.; Gašparovič, H.; Stelitano, G.; Sammartino, J.C.; Korduláková, J.; Governa, P.; Manetti, F.; Pasca, M.R.; Chiarelli, L.R.; et al. The veterinary anti-parasitic selamectin is a novel inhibitor of the Mycobacterium tuberculosis DprE1 enzyme. Int. J. Mol. Sci. 2022, 23, 771. [Google Scholar] [CrossRef] [PubMed]
- Cahill, C.; Cox, D.J.; O’Connell, F.; Basdeo, S.A.; Gogan, K.M.; Ó’Maoldomhnaigh, C.; O’Sullivan, J.; Keane, J.; Phelan, J.J. The effect of tuberculosis antimicrobials on the immunometabolic profiles of primary human macrophages stimulated with Mycobacterium tuberculosis. Int. J. Mol. Sci. 2021, 22, 12189. [Google Scholar] [CrossRef] [PubMed]
- Popovici, C.; Pavel, C.-M.; Sunel, V.; Cheptea, C.; Dimitriu, D.G.; Dorohoi, D.O.; David, D.; Closca, V.; Popa, M. Optimized synthesis of new thiosemicarbazide derivatives with tuberculostatic activity. Int. J. Mol. Sci. 2021, 22, 12139. [Google Scholar] [CrossRef] [PubMed]
- Noschka, R.; Wondany, F.; Kizilsavas, G.; Weil, T.; Weidinger, G.; Walther, P.; Michaelis, J.; Stenger, S. Gran1: A granulysin-derived peptide with potent activity against intracellular Mycobacterium tuberculosis. Int. J. Mol. Sci. 2021, 22, 8392. [Google Scholar] [CrossRef] [PubMed]
- Egorova, A.; Salina, E.G.; Makarov, V. Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives. Int. J. Mol. Sci. 2021, 22, 13317. [Google Scholar] [CrossRef] [PubMed]
- Ejalonibu, M.A.; Ogundare, S.A.; Elrashedy, A.A.; Ejalonibu, M.A.; Lawal, M.M.; Mhlongo, N.N.; Kumalo, H.M. Drug discovery for Mycobacterium tuberculosis using structure-based computer-aided drug design approach. Int. J. Mol. Sci. 2021, 22, 13259. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Degiacomi, G.; Makarov, V.; Pasca, M.R.; Chiarelli, L.R. New Drugs and Novel Cellular Targets against Tuberculosis. Int. J. Mol. Sci. 2022, 23, 13680. https://doi.org/10.3390/ijms232213680
Degiacomi G, Makarov V, Pasca MR, Chiarelli LR. New Drugs and Novel Cellular Targets against Tuberculosis. International Journal of Molecular Sciences. 2022; 23(22):13680. https://doi.org/10.3390/ijms232213680
Chicago/Turabian StyleDegiacomi, Giulia, Vadim Makarov, Maria Rosalia Pasca, and Laurent Roberto Chiarelli. 2022. "New Drugs and Novel Cellular Targets against Tuberculosis" International Journal of Molecular Sciences 23, no. 22: 13680. https://doi.org/10.3390/ijms232213680